Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation-Reference-Cited by-同舟云学术

Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation

Published:2004-10-19 Issue:8 Volume:25 Page:345-352
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Dutta Sandeep,Zhang Yiming

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference10 articles.

1. Depakote® Tablets Product Information. Divalproex Sodium Delayed-Release Tablets. Abbott Laboratories, Inc.: North Chicago, IL 60064, USA, 2002.

2. Depakote® ER Tablets Product Information. Divalproex Sodium Extended-Release Tablets. Abbott Laboratories, Inc.: North Chicago, IL 60064, USA, 2003.

3. Surgical Treatment of Frontal Lobe Epilepsy

4. Divalproex to Divalproex Extended Release Conversion

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-Based Bioequivalence Analysis to Assess and Predict the Relative Bioavailability of Valproic Acid Formulations;European Journal of Drug Metabolism and Pharmacokinetics;2024-06-14

2. Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials;Frontiers in Pharmacology;2022-04-05

3. Seizure Management in the Intensive Care Unit;Current Treatment Options in Neurology;2021-10-21

4. Advances with extended and controlled release formulations of antiepileptics in the elderly;Expert Opinion on Pharmacotherapy;2018-11-27

5. What to do when patients with epilepsy cannot take their usual oral medications;Practical Neurology;2017-01-10